Cian McCarthy Profile picture
Dec 8, 2021 6 tweets 12 min read Read on X
Session 3 of #BacktoHeart21 happening now and covering #Lipids moderated by @FaRodriguezMD @PamelaBMorris & @DLBHATTMD!

First up @alanbrownmd covers COVID-19 and statin therapy! Promising observational data and many RCTs ongoing!

@MedscapeLIVE ImageImageImageImage
@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE Next up @PamelaBMorris discusses lipid lowering beyond statins!

More data to come for bempedoic acid, Evinacumab, and Inclisiran! Lots of options emerging for LDL lowering ImageImageImageImage
@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE @DrRSRosenson provides a expert review of HIV and ischemic heart disease!

> HIV patients have high rates of CV events
> Lipid lowering therapy are underutilized
> 1/4 patients are treated with contraindicated statins or doses ImageImageImageImage
@FaRodriguezMD @PamelaBMorris @DLBHATTMD @alanbrownmd @MedscapeLIVE @DrRSRosenson @JSaseenPharmD discussed TG lowering therapy and CV disease!

> EPA only omega 3 products beneficial with significant reduction in CV events demonstrated in the REDUCE-IT trial
> Be mindful of the increased risk of AF ImageImageImageImage
@PamTaubMD discusses primary prevention for high-risk patients

> Dr. Taub makes a strong argument for incorporting more biomarkers beyond LDL to guide risk and management
> More personalized management needed to prevent events! ImageImageImageImage
@DLBHATTMD provides a masterclass overview on antiplatelet and anticoagulant therapy for CVD to wrap up the session!

Dr. Bhatt discusses duration of DAPT & addition of low dose anticoagulation for stable CAD!

#BacktoHeart21 ImageImageImageImage

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Cian McCarthy

Cian McCarthy Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @CianPMcCarthy

Dec 9, 2021
Session IV of #BacktoHeart21 covering all things cardiometabolic disease occuring now!

First up, @JJheart_doc discusses SGLTI2 for T2DM and ASCVD!

@MedscapeLIVE
Next up @busediabetes discusses GLP-1 agonists in patients with T2DM and ASVCD!
Dr. Darren McGuire discusses hypoglycemia and adverse outcomes.

> Hypoglycemia associated with higher risk of MACE and mortality
> Adverse outcomes may be reflective of frailty/disease severity rather than causal
Read 6 tweets
Dec 9, 2021
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization now published!

Here are my top takeaways!

Thread/

Link:
jacc.org/doi/10.1016/j.…
2/ For stable CAD and left main stenosis, CABG is recommended (Class 1). PCI is a reasonable option if low-medium anatomic complexity and if equally suitable to PCI compared to CABG (Class IIa)
3/ In general, revascularization is recommended (Class 1) for stable ischemic heart disease for 1) refractory angina despite medical therapy, 2) left main disease, 3) ischemic cardioyopathy and suitable for CABG. See this figure for details
Read 8 tweets
Oct 28, 2021
⚡️💥BREAKING 💥⚡️
The 2021 ACC/AHA/CHEST/SAEM/SCCT/SCMR Chest Pain guideline was published online today!

Link to paper:
jacc.org/doi/10.1016/j.…

Here are my personal takeaways!
👇

Thread /
2/ First, huge congratulations to the chair @DrMarthaGulati, vice-chairs Drs. Levy and Mukherjee and the writing committee including @DLBHATTMD, @RonBlankstein @RBP0612 @labunne @ErikHessMD @docHj @lesleejshaw. Incredible work! Not an easy task to put this together..
3/ Let’s start with acute chest pain in the ED. The committee advise against using the term atypical chest pain; instead favoring categorizing as cardiac, possibly cardiac, and non-cardiac chest pain. I like this concept a lot!
Read 15 tweets
Aug 29, 2020
My 15 highlights 💡from the 2020 ESC NSTE-ACS guideline:

1. Hs troponins recommeded over conventional assays 🧪
2. ESC 0'1 and 0'2 algorithms preferred over 0'3
3. TTE recommended for all patients.
4. If rule-out using ED algorithm but still have concern for ACS, a non-invasive modality is preferred to invasive coronary angio
5. Pre-treatment with P2Y12 not recommended prior to invasive coronary angiogram
6. Prasugrel preferred over ticagrelor if undergoing PCI 💊
7. Both preferred over clopidogrel unless not available
8. UFH preferred to LMWH for NSTEMI 💉
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(